321 filings
8-K
AUPH
Aurinia Pharmaceuticals Inc
29 Feb 24
Departure of Directors or Certain Officers
4:10pm
10-K
2023 FY
AUPH
Aurinia Pharmaceuticals Inc
Annual report
15 Feb 24
6:16am
8-K
AUPH
Aurinia Pharmaceuticals Inc
15 Feb 24
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
6:06am
8-K
AUPH
Aurinia Pharmaceuticals Inc
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am
10-Q
2023 Q3
AUPH
Aurinia Pharmaceuticals Inc
Quarterly report
2 Nov 23
6:05am
8-K
zjw7cm6vv
2 Nov 23
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
6:01am
8-K
62c277ty0geudye ddw
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
8-K
9vrxoq
21 Aug 23
Dr. Daniel G. Billen appointed Chair of the Board of Directors
4:11pm
8-K
obp5z4 urw2
3 Aug 23
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
6:03am
PX14A6G
6jf1qt
6 Jul 23
Letter to shareholders
8:33am
8-K
zof5ecxz2db 8tcomip
3 Jul 23
Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
6:06am
PX14A6G
w3kq2cpi
1 Jun 23
Letter to shareholders
2:01pm
S-8
49ygzeb7 mezw
26 May 23
Registration of securities for employees
4:39pm
8-K
2tchb 3flz
17 May 23
Submission of Matters to a Vote of Security Holders
4:03pm
PX14A6G
0xgp65brvgv9g9a 8grq
17 May 23
Letter to shareholders
4:00pm
PX14A6G
x2twruelehuiqce7i5
11 May 23
Letter to shareholders
11:34am
DEFA14A
6ksholse1hq8
8 May 23
Additional proxy soliciting materials
4:04pm
PX14A6G
ync6p5
5 May 23
Letter to shareholders
11:17am